LabGenomics Co. Ltd Total Liabilities
LabGenomics Co. Ltd total liabilities. Based on the latest financial reports, LabGenomics Co. Ltd (084650) has total liabilities worth ₩76.00 Billion KRW (≈ $51.50 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check LabGenomics Co. Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of LabGenomics Co. Ltd (2014–2024)
Total liabilities of LabGenomics Co. Ltd from 2014 to 2024. This chart illustrates how LabGenomics Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of LabGenomics Co. Ltd to see how much of total assets are deployed in long-term investments.
LabGenomics Co. Ltd Competitors by Total Liabilities
The table below lists competitors of LabGenomics Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Admiralty Resources NL
AU:ADY
|
Australia | AU$18.25 Million |
|
Four Leaf Acquisition Corporation Class A Common Stock
NASDAQ:FORL
|
USA | $26.89 Million |
|
Primega Group Holdings Limited
NASDAQ:ZDAI
|
USA | $864.97K |
|
Leyand International Tbk
JK:LAPD
|
Indonesia | Rp152.73 Billion |
|
BSL Corp Bhd
KLSE:7221
|
Malaysia | RM83.06 Million |
|
TAG Oil Ltd.
V:TAO
|
Canada | CA$2.43 Million |
|
i2S SA
PA:ALI2S
|
France | €6.67 Million |
|
Tvardi Therapeutics, Inc.
NASDAQ:TVRD
|
USA | $9.13 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down LabGenomics Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is LabGenomics Co. Ltd's balance sheet.
Liquidity & Leverage Metrics
LabGenomics Co. Ltd Total Liabilities Ratios Explained
LabGenomics Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.83 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LabGenomics Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LabGenomics Co. Ltd (2014–2024)
The table below shows the annual total liabilities of LabGenomics Co. Ltd from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩79.35 Billion ≈ $53.77 Million |
-6.99% |
| 2023-12-31 | ₩85.31 Billion ≈ $57.82 Million |
+106.46% |
| 2022-12-31 | ₩41.32 Billion ≈ $28.00 Million |
-11.27% |
| 2021-12-31 | ₩46.57 Billion ≈ $31.56 Million |
+67.40% |
| 2020-12-31 | ₩27.82 Billion ≈ $18.85 Million |
+45.96% |
| 2019-12-31 | ₩19.06 Billion ≈ $12.92 Million |
+12.17% |
| 2018-12-31 | ₩16.99 Billion ≈ $11.52 Million |
-3.02% |
| 2017-12-31 | ₩17.52 Billion ≈ $11.87 Million |
-3.59% |
| 2016-12-31 | ₩18.17 Billion ≈ $12.32 Million |
+90.55% |
| 2015-12-31 | ₩9.54 Billion ≈ $6.46 Million |
-3.26% |
| 2014-12-31 | ₩9.86 Billion ≈ $6.68 Million |
-- |
About LabGenomics Co. Ltd
LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea.